VVUS 3.07 Vivus Inc $VVUS Hit a 52 week low of 3.05 Closing

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
VVUS 3.07 Vivus Inc $VVUS Hit a 52 week low of 3.05 Closing the day 10:44 at 3.07 -0.04 -1.29% With a day low of 3.05 and a total volume of 453,844.

VVUS Recent Posts: http://investorshangout.com/VIVUS-Inc-VVUS-55858/

VVUS Vivus Inc Recent Headline News

Janssen Is Working Its Way Toward Anti-Obesity
Spencer Osborne - at Seeking Alpha - Mon Nov 17, 4:14PM CST

ZFGN: 20.30 (+0.18), OREX: 5.59 (+0.08), NVO: 44.13 (+0.53), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

EnteroMedics May Enter The Obesity Space - What Does It Mean?
Spencer Osborne - at Seeking Alpha - Mon Nov 17, 3:43PM CST

OREX: 5.59 (+0.08), ETRM: 1.28 (-0.01), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

For This Obesity Drug, Europe Trumps the U.S.
Brian Orelli, The Motley Fool - Motley Fool - Mon Nov 17, 3:00PM CST
The launch of Orexigen Therapeutics ' obesity drug Contrave isn't off to the best start. As Chief Commercial Officer Mark Booth put it during the company's latest conference call: Unfortunately, like many new tactics, there have been some...
OREX: 5.59 (+0.08), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

ARNA Management And Investors Underestimating The Potential Of Belviq And Phentermine Combination
Lance Brofman - at Seeking Alpha - Thu Nov 13, 8:52AM CST

OREX: 5.59 (+0.08), HLF: 38.39 (-0.11), NVO: 44.13 (+0.53), VVUS: 3.07 (-0.04), AMGN: 160.83 (+1.69), GSK: 46.26 (+0.38), ARNA: 4.46 (-0.04)

Critical Alerts For American Eagle Outfitters, Novartis, VIVUS, King Digital and Canadian Solar Released By InvestorsObserver
PR Newswire - Thu Nov 13, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for AEO, NVS, VVUS, KING and CSIQ.
AEO: 13.20 (-0.14), VVUS: 3.07 (-0.04), CSIQ: 26.89 (+0.52), KING: 15.69 (-0.16), NVS: 95.71 (+1.33)

Bel-Phen Pilot Study News, Hold On To Your Shares
Rx Stocks - at Seeking Alpha - Tue Nov 11, 12:13PM CST

OREX: 5.59 (+0.08), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

Orexigen Turns Around with Q3 Earnings Beat, Shares Soar - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 10:20AM CST
Orexigen (OREX) swung to profit in the third quarter of 2014 with earnings of 9 cents per share beating the Zacks Consensus Estimate of 5 cents.
OREX: 5.59 (+0.08), VVUS: 3.07 (-0.04), AMAG: 36.28 (+1.52)

Can Arena Pharmaceuticals Inc. Overcome Belviq's Slow Launch?
George Budwell, The Motley Fool - Motley Fool - Tue Nov 11, 10:15AM CST
The new generation of diet pills approved by the Food and Drug Administration have stumbled out of the gate. Specifically,  Arena Pharmaceuticals '   Belviq and  VIVUS 's   Qsymia reported a combined 283,000 prescriptions in the third quarter, with...
PFE: 30.58 (+0.26), VVUS: 3.07 (-0.04), GSK: 46.26 (+0.38), ARNA: 4.46 (-0.04)

Why Orexigen Therapeutics, Inc. Stock Skyrocketed
Sean Williams, The Motley Fool - Motley Fool - Mon Nov 10, 5:52PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Orexigen Therapeutics , a...
OREX: 5.59 (+0.08), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

Arena And Vivus Investors Need To Watch Orexigen
Spencer Osborne - at Seeking Alpha - Mon Nov 10, 12:24PM CST

OREX: 5.59 (+0.08), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

Orexigen rises as weight loss drug review proceeds
AP - Mon Nov 10, 10:02AM CST
NEW YORK (AP) — Shares of Orexigen Therapeutics Inc. jumped Monday after the company said a European Union review of its weight loss drug Contrave, which was approved in the U.S. in September, is progressing on schedule.
OREX: 5.59 (+0.08), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

3 Crashing Stocks: Is 1 a Buy?
Motley Fool Staff - Motley Fool - Sun Nov 09, 10:45AM CST
Even though the overall stock market is very close to its record highs, many stocks have not fared so well. In fact, some stocks have gotten crushed recently. We asked three of our analysts to give their opinions on stocks that have been beaten...
VVUS: 3.07 (-0.04), SNY: 48.28 (+0.74), GNW: 9.35 (+0.02), REGN: 410.83 (+11.18)

Belviq Sales Dip Slightly - Quarter Is Flat Thus Far
Spencer Osborne - at Seeking Alpha - Fri Nov 07, 12:02PM CST

VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

VIVUS Posts Narrower-than-Expected Q3 Loss, Revenues Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 3:45PM CST
VIVUS Inc.'s (VVUS) third-quarter 2014 loss of 11 cents per share was much narrower than the Zacks Consensus Estimate of a loss of 21 cents.
AUXL: 32.97 (+0.79), VVUS: 3.07 (-0.04), AMAG: 36.28 (+1.52), SNY: 48.28 (+0.74)

Vivus Beats The Street On Milestone Payment For ED Drug
Spencer Osborne - at Seeking Alpha - Thu Nov 06, 7:59AM CST

OREX: 5.59 (+0.08), VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

Will Belviq Advertising Pick Up Again?
Spencer Osborne - at Seeking Alpha - Thu Nov 06, 7:55AM CST

VVUS: 3.07 (-0.04), ARNA: 4.46 (-0.04)

VIVUS' (VVUS) CEO Seth Fischer on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 6:18PM CST

VVUS: 3.07 (-0.04)

Vivus tops Street 3Q forecasts
Automated Insights - Wed Nov 05, 4:45PM CST
MOUNTAIN VIEW, Calif. (AP) _ Vivus Inc. (VVUS) on Wednesday reported a third-quarter loss of $15.8 million.
VVUS: 3.07 (-0.04)

Vivus Q3 revenues up 24%
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 3:29PM CST

VVUS: 3.07 (-0.04)

Vivus (VVUS) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 3:25PM CST

VVUS: 3.07 (-0.04)

VIVUS, Inc. (VVUSQ) Stock Research Links

VVUSQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Law Firm Gains Strength with Strategic New Hires

Updated Category News Views 1

Catching the latest twist in the legal scene, veteran criminal defense attorney John T. Floyd is stiffening the backbone of his Houston-based firm. Snagging both Christopher Choate and Mia Floyd, he's set to fortify his team representing folks caught in the snarl of Texas and federal criminal courts. New Faces, Massive Expertise Let's dig into Choate's credentials first....

Continue Reading
Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Updated Category News Views 3

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Continue Reading
Shareholder Rights in Focus: Examining Key Buyouts

Updated Category News Views 4

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Continue Reading
Hair Syrup's Big U.S. Leap: Target Welcomes Viral Brand

Updated Category News Views 2

From Kitchen Experiment to U.S. Debut Here's a story that barely fits the tight mold of your typical business textbook. Hair Syrup, born from the brain of a university student tinkering at her kitchen table, is about to make waves across the pond. Lucie Macleod did what many dream of—she took a DIY hair oil project and spun it into a multimillion-dollar brand, now set...

Continue Reading
South Florida Donor Network Honors 52 Heroic Donors

Updated Category News Views 5

A Heartfelt Tribute to Lifesavers You ever been to a gathering that reminds you how deeply human connections run? That's what happened at The Diplomat Beach Resort in Hollywood. South Florida Donor Network (SFDN) pulled together a ceremony honoring 52 donor heroes whose legacies beat strong through the recipients living thanks to their gifts. An Event Worth Attending...

Continue Reading
ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 4

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading
Health Net's $2M Boost for Stanislaus Affordable Housing

Updated Category News Views 3

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....

Continue Reading
Monib Zirvi's Dermatology Excellence Honored in 2026

Updated Category News Views 4

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

Continue Reading
Maurices Strengthens Position with Key Refinancing Deal

Updated Category News Views 2

Maurices' Bold Financial Maneuver When a retailer like Maurices, with its near-century-long history, decides to play in the financial arena, it sure makes my ears perk up. This Duluth-based women's fashion retailer isn't just dipping its toes in—it's executing a full-blown refinancing blitzkrieg and coming out stronger. Announcing the completion of its refinancing plan...

Continue Reading
Tampa General’s Innovation Excellence Earns No. 20 Spot

Updated Category News Views 7

A Bold Leap into Innovation at Tampa General There's a heck of a lot going on down in Tampa that's worth more than just a golf clap. Tampa General Hospital (TGH) just snagged the 20th spot on Fast Company's Best Workplaces for Innovators list, and let me tell you, that’s no small feat amidst the heavy hitters in verticals like biotech and consumer goods. It takes guts...

Continue Reading

Top 5 Most Recently Viewed Articles

Stellantis Broadens Employee Stock Ownership to Boost Engagement

Updated Category News Views 226

Stellantis Expands Employee Share Purchase Program Stellantis N.V. (NYSE: STLA), a prominent global player in the automotive industry, has made an exciting announcement regarding the expansion of its employee share purchase initiative known as 'Shares to Win'. This program is designed to promote ownership among its employees and is now available to nearly the entire...

Continue Reading
Bitcoin ETF Inflows Surge Beyond $400 Million Amidst Market Shifts

Updated Category News Views 35

Bitcoin Sees Significant ETF Inflows as Prices Rally Bitcoin and Ethereum exchange-traded funds (ETFs) have witnessed an impressive surge in inflows totaling approximately $407 million in just one week. This remarkable increase in investment can be largely attributed to shifting political dynamics rather than traditional monetary policy factors. Political Climate Drives...

Continue Reading
Harris Debates Trump: Polls Reveal Unchanged Voter Preferences

Updated Category News Views 123

Harris and Trump Face Off in Crucial Political Debate The latest presidential debate highlighted the contrasting positions of Republican candidate Donald Trump and Democratic contender Kamala Harris. However, recent polling data suggests there have been only minor changes in voter preferences after the debate. Polling Overview Recent figures show Kamala Harris with 51%...

Continue Reading
Soligenix Inc. (NASDAQ: SNGX) Revolutionizes Treatment for CTCL

Updated Category News Views 138

Soligenix Inc. Leads the Charge in Rare Disease Treatment Soligenix Inc. (NASDAQ: SNGX) is at the forefront of developing groundbreaking therapies tailored for patients suffering from rare diseases, particularly those affecting the aging population. As the healthcare landscape continues to evolve, chronic conditions and rare diseases increasingly create significant...

Continue Reading
What Are Polymarket Traders Anticipating for Bitcoin's Price?

Updated Category News Views 74

Bitcoin Price Predictions and Market Sentiment Polymarket bettors are closely watching Bitcoin's performance this November, particularly focusing on whether the cryptocurrency will cross the $100,000 mark. Current speculation shows a striking 79% probability that Bitcoin will achieve this significant milestone, especially after hitting an all-time high of $98,310...

Continue Reading